Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Tonix Pharmaceuticals Holding Corp. publishes a filing, an earnings call transcript or a press release.

Get TNXP alerts

About James Hunter

James Hunter is recorded as Board Member at Tonix Pharmaceuticals Holding Corp. (TNXP). The newest filing on record that lists James Hunter as Board Member at Tonix Pharmaceuticals Holding Corp. (TNXP) is dated March 30, 2026. Tonix Pharmaceuticals Holding Corp. reported in an 8-K filed May 7, 2026 that James Hunter was appointed Director, effective May 7, 2026. Tonix Pharmaceuticals Holding Corp. reported in an 8-K filed June 13, 2025 that James Hunter was appointed member of the Board, effective June 12, 2025. Tonix Pharmaceuticals Holding Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tonix Pharmaceuticals Holding Corp. includes Seth Lederman (CEO and Board Member), Bradley Saenger (CFO), Siobhan Fogarty (CTO) and 7 others.

“The Company's shareholders elected nine individuals to the Board of Directors as set forth below:”
Tonix Pharmaceuticals Holding Corp. Form 8-K, filed May 7, 2026 · Read the filing
“Effective as of June 12, 2025, the Board of Directors (the "Board") of Tonix Pharmaceuticals Holding Corp. (the "Company"), on the recommendation of its Nominating and Corporate Governance Committee, appointed James Hunter as a member of the Board.”
Tonix Pharmaceuticals Holding Corp. Form 8-K, filed June 13, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Tonix Pharmaceuticals Holding Corp.

Recent activity